NCT00725933View on ClinicalTrials.gov

Administration of BIIB028 to Subjects With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Advanced Solid Tumors
Interventions
DRUG

BIIB028

IV infusion administered twice weekly until disease progression or unacceptable toxicity

Trial Locations (3)

77030

Research Site, Houston

92024

Research Site, Encinitas

Unknown

Research Site, Los Angeles

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY